
Lawless+Pines™ Launches "The One Serum" with 99 Percent Actives for Radiant Skin All Year Long
SAN FRANCISCO, Nov. 17, 2015 /PRNewswire/ -- Lifelong skin care fanatics Matthew Lawless and Gary Pineda introduce Lawless+Pines™, a brand of innovative facial care products for men and women. Just in time for the dry winter months, the line debuts with ultra-hydrating "The One Serum," created with 99 percent active ingredients and formulated to combat against premature aging.
Photo - http://photos.prnewswire.com/prnh/20151116/287591
Photo - http://photos.prnewswire.com/prnh/20151116/287590
"We have always been interested in skin care and the science behind what goes into a product that truly delivers results," said Lawless, co-founder, Lawless+Pines™. "In developing our brand we focused on active ingredients and are very excited to launch with our serum, made with eight cutting-edge peptides to promote hydration and address signs of aging like loss of collagen, wrinkling and hyper-pigmentation."
The One Serum combines revolutionary peptides such as Palmitoyl Tetrapeptide-7 to promote collagen synthesis, Hexapeptide-11 to firm and tone, Pentapeptide-18 and Acetyl Octapeptide-3 to reduce and prevent wrinkles, Nonapeptide-1 to brighten, and Tripeptide-1 to protect against harmful UV damage.
The One Serum, 14.78ml/.499 ounces, retails for $98 and is available at lawlessandpines.com. Shoppers interested trying the product can request free samples here.
About Lawless+Pines™
Matthew Lawless and Gary Pineda founded Lawless+Pines™ to pursue their passion for creating products that make the skin glow. Formulated by some of the most advanced cosmetic chemists in the country, their products offer advanced skin care solutions based on using high levels of advanced active ingredients that give superior results and are cruelty free, never tested on animals. Be the first to hear about new products and get special offers on Facebook and @lawlessandpines on Instagram.
Media contact:
Matthew Lawless
310-591-9209
SOURCE Lawless+Pines
Share this article